Biogen Inc. buy hoffi69
Start price
08.05.12
/
50%
€101.61
Target price
23.10.12
€110.00
Performance (%)
7.22%
End price
23.10.12
€108.95
Summary
This prediction ended on 23.10.12 with a price of €108.95. The BUY prediction by hoffi69 finished with a performance of 7.22%. hoffi69 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biogen Inc. | -0.144% | -0.144% | -16.733% | -24.525% |
iShares Core DAX® | -0.612% | 0.567% | 12.585% | 14.838% |
iShares Nasdaq 100 | -3.018% | -3.205% | 26.208% | 38.328% |
iShares Nikkei 225® | -2.647% | 0.330% | 9.482% | 5.652% |
iShares S&P 500 | -1.932% | -1.126% | 23.191% | 38.791% |
Comments by hoffi69 for this prediction
In the thread Biogen Inc. diskutieren
Megatrend
Ähnlich wie Amgen steht auch Biogen grundsolide da.In den Megatrend molekularbiologisch/gentechnisch hergestellter Medikamente lohnt sich auch in unruhigen Börsenzeiten einzusteigen.Die Nachfrage wird weiter steigen.
(Vom Mitglied beendet)